4.7 Article

Membrane Chromatography-Based Downstream Processing for Cell-Culture Produced Influenza Vaccines

期刊

VACCINES
卷 10, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/vaccines10081310

关键词

influenza strains; H1N1; H3N2; and H7N9; cell-culture derived influenza vaccine; downstream process; membrane-based chromatography

资金

  1. Canadian Institutes of Health Research (CIHR) [CPG-151958]
  2. Natural Sciences and Engineering Research Council (NSERC) [CHRPJ508335-17]
  3. Canada Research Chair [CRC-240394]

向作者/读者索取更多资源

Developing robust bioprocesses for pandemic influenza vaccines is crucial. A membrane chromatography-based downstream processing platform was established, achieving efficient viral recovery and reduction of host cell DNA and proteins. This method holds promise as an alternative to current industrial purification methods for influenza vaccines.
New influenza strains are constantly emerging, causing seasonal epidemics and raising concerns to the risk of a new global pandemic. Since vaccination is an effective method to prevent the spread of the disease and reduce its severity, the development of robust bioprocesses for producing pandemic influenza vaccines is exceptionally important. Herein, a membrane chromatography-based downstream processing platform with a demonstrated industrial application potential was established. Cell culture-derived influenza virus H1N1/A/PR/8/34 was harvested from benchtop bioreactor cultures. For the clarification of the cell culture broth, a depth filtration was selected as an alternative to centrifugation. After inactivation, an anion exchange chromatography membrane was used for viral capture and further processing. Additionally, two pandemic influenza virus strains, the H7N9 subtype of the A/Anhui/1/2013 and H3N2/A/Hong Kong/8/64, were successfully processed through similar downstream process steps establishing optimized process parameters. Overall, 41.3-62.5% viral recovery was achieved, with the removal of 86.3-96.5% host cell DNA and 95.5-99.7% of proteins. The proposed membrane chromatography purification is a scalable and generic method for the processing of different influenza strains and is a promising alternative to the current industrial purification of influenza vaccines based on ultracentrifugation methodologies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据